6. パーキンソン病 Parkinson disease Clinical trials / Disease details

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

4 trials found

diseases per page:

Showing 1 to 4 of 4 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03412513 (ClinicalTrials.gov)	July 17, 2017	21/1/2018	Mirabegron for Treatment of Overactive Bladder Symptoms in Patients With Parkinson's Disease	Mirabegronfor Treatment of Overactive Bladder Symptoms in Patients With Parkinson's Disease: a Doubl ...	Overactive Bladder;Parkinson Disease	Drug: Mirabegron;Drug: Placebo	Seoul National University Hospital	NULL	Unknown status	40 Years	80 Years	All	144	Phase 4	Korea, Republic of
2	JPRN-UMIN000043848	2017/01/10	29/04/2021	The safety and effectiveness of mirabegron in Parkinson's disease patients with overactive bladder	The safety and effectiveness of mirabegronin Parkinson's disease patients with overactive bladder : ...	Overactive bladder	Treatment group receiving daily mirabegron 50mg for 12 weeks Placebo group	Al Zahraa Hospital	NULL	Complete: follow-up complete	40years-old	70years-old	Male and Female	110	Not applicable	Asia(except Japan)
3	NCT02536976 (ClinicalTrials.gov)	December 2015	28/8/2015	Mirabegron in Parkinson Disease and Impaired Cognition	A Clinical Trial of Mirabegronfor Overactive Bladder Symptoms in Patients With Parkinson Disease and ...	Parkinson Disease;Overactive Bladder;Impaired Cognition	Drug: mirabegron;Drug: Placebo	HealthPartners Institute	NULL	Completed	25 Years	80 Years	All	7	Phase 4	United States
4	NCT02092181 (ClinicalTrials.gov)	March 2014	7/3/2014	A Pilot Study of Mirabegronand Behavioral Modification Including Pelvic Floor Exercise for Overactiv ...	A Pilot Study of Mirabegronand Behavioral Modification Including Pelvic Floor Exercise for Overactiv ...	Parkinsons Disease	Drug: Mirabegron;Drug: Placebo	Daniel Burdick, MD	Astellas Pharma US, Inc.	Completed	30 Years	85 Years	All	30	Phase 4	United States

First Previous1Next Last